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Abstract
The Steven-Johnson Syndrome (SJS) is a rare immune complex mediated hypersensitivity condition. Here we
report the case of Steven-Johnson Syndrome due to the co-administration of aceclofenac and cefixime. NSAIDs are
the rare type of medication that causes SJS and cefixime is a traditional medication that causes the condition. A 22-
years-old patient was admitted in the hospital with a complaint of fever for 15 days and he was treated by giving
aceclofenac, cefixime and general symptomatic treatment. On the 4th day of treatment erythromatous patches were
observed throughout the body. Laboratory investigations were performed and the case was identified as Steven-
Johnson Syndrome. The treatment was withdrawn and he was administered with steroids, amoxicillin, metronidazole
and general symptomatic treatment. The patient has recovered after a week.
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Introduction
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis
(TEN) are two forms of a life-threatening skin condition, in which cell
death causes the epidermis to separate from the dermis. The syndrome
is thought to be a hypersensitivity complex that affects the skin and the
mucous membranes. The majority of cases are idiopathic (without a
known cause). The main known cause is certain medications, followed
by infections and rarely cancers [1].
Stevens-Johnson syndrome (SJS) usually begins with fever, sore
throat, and fatigue, which is misdiagnosed and usually treated with
antibiotics. Ulcers and other lesions begin to appear in the mucous
membranes, almost always in the mouth and lips but also in the genital
and anal regions. Those in the mouth are usually extremely painful and
reduce the patient's ability to eat or drink. Conjunctivitis of the eyes
occurs in about 30% of children who develop SJS. A rash of round
lesions about an inch across arises on the face, trunk, arms and legs,
and soles of the feet, but usually not the scalp [2].
Medications that have traditionally been known to lead to SJS,
erythema multiform and toxic epidermal necrolysis include
sulphonamides (antibiotic), penicillin (antibiotic), cefixime
(antibiotic), barbiturates (sedative), lomotrigine and phenytoin
(eg.dilantin) (anticonvulsants). Combining lamotrigine with sodium
valproate increases the risk of SJS. Non-steroidal anti-inflammatory
drugs are a rare cause of SJS in adults; the risk is higher for older
patients, women and those initiating treatment. Typically, the
symptoms of drug-induced SJS arise within a week of starting the
medication. People with systemic lupus erythematosus or HIV-
infections are more susceptible to drug-induced SJS [3].
Cefixime is an oral third generation cephalosporin antibiotic used to
treat infections caused by bacteria. These include infections of the: Ear,
Nose, Sinuses, Throat, Chest, Lungs, Urinary system and
uncomplicated gonorrhoea caused by Neisseria gonorrhoeae. Adverse
Drug Reactions include diarrhoea, dyspepsia, nausea, vomiting.
Hypersensitivity reactions like skin rashes, utricaria and Stevens-
Johnson syndrome. Aceclofenac is an NSAID; NSAIDs are usually
indicated for the treatment of acute or chronic conditions where pain
and inflammation are present. Adverse drug reaction include
gastrointestinal (GI) and renal effects. NSAIDs are also implicated in
some cases of Stevens-Johnson syndrome.
Objectives
To report the AE’s and to prevent it from further happening in
tertiary and primary hospitals for improvement of quality of life of the
patient’s.
Study design
It is a prospective, retrospective observational study conducted in a
private and institutional hospitals of rural India.
Methods
A Prospective case study during daily ward rounds done on patients
in rural hospital of India.
Case History
A 22-years-old male patient was admitted in private medical college
hospital (S.V.S hospital, Mahabubnagar) with the complaint of fever for
15 days. The patient has been given aceclofenac, b-complex and
T.cefixime orally twice a day. The drugs were started on 1st Oct, 2015
and stopped on 7th Oct, 2015. On 4th Oct the patient developed
erythromatous patches throughout the body (Steven-Johnsons
Syndrome) particularly muco-cutaneous junctions. The laboratory
data show serum creatinine 1.8 gm/dl , blood urea 73 mg/dl, Hb 15
g/dl, TLC 6600, neutrophils 60%, eosinophils 2%, lymphocytes 36%,
monocytes 2%, platelets 1.9 lakhs and the tests for malarial and dengue
parasites were negative. The drug was withdrawn after the advent of
the reaction and the patient was given steroid, antibiotics like
amoxicillin, metronidazole and symptomatic treatment (paracetamol,
IV fluids). The patient was improved markedly and urea level was
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reverted back to normal. The reaction has never taken place after
treatment.
Discussion
The SJS is usually caused by disorder of the immune system. The
immune reaction can be triggered by infections, drugs or medications.
As the patient doesn’t have any kind of infections so the drugs
prescribed are reviewed and stopped.
Cefixime has sulphur in its structure. The term sulphur allergy is
misleading and dangerous and not be used. Patients with sulfonamide
induced toxic epidermal necrolysis (TEN) have been shown to have a
slow acetylator genotype resulting in increased production of
sulfonamide hydroxylamine via p-450 pathway. These drug metabolites
have direct toxic effects or act via a hapten-mediated mechanism to
break self-tolerance to endogenous proteins. This is the reason behind
developing the erythematous patches due to the administration of
cefixime, NSAIDS are also prescribed so the effect may be increased
due to the co-administration of both the SJS causing drugs.
Conclusion
As aceclofenac and cefixime are frequently used concurrently, it is
important to recognize their possible interaction. Early recognition of
the ADR and removal of the offending drug can save the patient from
unnecessary investigations and also reduce the medical expenses. The
above ADR was discussed in the clinical review meeting, documented
and submitted to the pharmacovigilance department in the hospital.
Author’s Statement
The study conducted post approval from IRB/IEC from rural
hospitals. This study has a limitation included lack of funding from
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